Patents by Inventor Nitesh Nalinchandra Pandya

Nitesh Nalinchandra Pandya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9682045
    Abstract: The present invention relates to pharmaceutical compositions comprising a thyroid hormone drug. The invention also relates to processes for the preparation of such compositions.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: June 20, 2017
    Assignee: CADILA HEALTHCARE LIMITED
    Inventors: Muthaiyyan Essakimuthu Kannan, Nitesh Nalinchandra Pandya, Chetan Kacharabhai Patel
  • Publication number: 20160143855
    Abstract: The present invention relates to pharmaceutical compositions comprising a thyroid hormone drug. The invention also relates to processes for the preparation of such compositions.
    Type: Application
    Filed: November 20, 2015
    Publication date: May 26, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Muthaiyyan Essakimuthu KANNAN, Nitesh Nalinchandra PANDYA, Chetan Kacharabhai PATEL
  • Publication number: 20100178333
    Abstract: Once a day sustained release solid oral dosage form of phenothiazine derivative preferably the dibenzothiazepine derivative and their pharmaceutically acceptable salts comprising of a channelizer, rate controlling polymer and suitable pharmaceutically acceptable excipients. The formulation of the present invention is in the form of tablet or capsule which provides a sustained drug action upto 24 hours upon single dose administration.
    Type: Application
    Filed: January 23, 2007
    Publication date: July 15, 2010
    Applicant: ASTRON RESEARCH LIMITED
    Inventors: Jayanta Kumar Mandal, Nitesh Nalinchandra Pandya, Kirti Bansidhar Maheshwari
  • Publication number: 20090196923
    Abstract: The present invention relates to pharmaceutical formulation of antiepileptic drug preferably oxcarbazepine. The formulation comprises multiple tablets or pellets of immediate release or controlled release nature, which are filled, inside the capsule to provides drug effect for 24 hours and is suitable for once a day administration. The patent also provides process of preparation of the dosage form.
    Type: Application
    Filed: April 23, 2007
    Publication date: August 6, 2009
    Inventors: Jayanta Kumar Mandal, Nitesh Nalinchandra Pandya, Sumitra Ashok Pillai, Kirti Bansidhar Maheshwari